Toggle Main Menu Toggle Search

Open Access padlockePrints

Retinal thickness in Parkinson's disease

Lookup NU author(s): Dr Neil Archibald, Michael Clarke, Dr Urs Mosimann, Professor David Burn

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background: Visual symptoms are common in Parkinson's disease with studies consistently demonstrating reductions in visual acuity, contrast sensitivity, colour and motion perception as well as alterations in electroretinogram latencies and amplitudes. Optical coherence tomography can examine retinal structure non-invasively and retinal thinning has been suggested as a potential biomarker for neurodegeneration in Parkinson's disease. Our aim was to examine the retinal thickness of a cohort of Parkinson's disease subjects (and age-matched controls) to establish the practical utility of optical coherence tomography in a representative older Parkinson's disease group. Methods: Fifty-one established Parkinson's disease subjects and 25 healthy controls were subjected to ophthalmological assessment and optical coherence tomography (Zeiss Stratus 3000 (TM)) of macular thickness and volume and retinal nerve fibre thickness around the optic nerve head. Twenty four percent of control and 20% of Parkinson's disease subjects were excluded from final analysis due to co-morbid ocular pathology. Further data was excluded either due to poor tolerability of optical coherence tomography or poor quality scans. Results: Despite a reduction in both visual acuity and contrast sensitivity in the residual evaluable Parkinson's disease cohort, we did not detect any differences between the two study groups for any measures of retinal thickness, in contrast to previously published work. Conclusions: In addition to technical problems inherent in the evaluation, the lack of difference between Parkinson's disease and healthy control subjects suggests longitudinal studies, employing newer techniques, will be required to define the role of optical coherence tomography as a potential diagnostic biomarker. (C) 2011 Elsevier Ltd. All rights reserved.


Publication metadata

Author(s): Archibald NK, Clarke MP, Mosimann UP, Burn DJ

Publication type: Article

Publication status: Published

Journal: Parkinsonism & Related Disorders

Year: 2011

Volume: 17

Issue: 6

Pages: 431-436

Print publication date: 31/03/2011

ISSN (print): 1353-8020

ISSN (electronic): 1873-5126

Publisher: Elsevier Ltd

URL: http://dx.doi.org/10.1016/j.parkreldis.2011.03.004

DOI: 10.1016/j.parkreldis.2011.03.004


Altmetrics

Altmetrics provided by Altmetric


Actions

Find at Newcastle University icon    Link to this publication


Share